CorNova is a medical device company founded in 2003 that is headquartered in Burlington, MA with offices in Munich, Germany and Buenos Aires, Argentina. We are focused on developing next-generation endovascular products. These products include breakthrough technologies in advanced materials, coatings, cardiovascular diagnostics, and treatments designed to revolutionize the field of interventional medicine.

CorNova is uniquely positioned to take advantage of innovative endovascular technologies. CorNova's unified relationship with its strategic partners allows us to build value and opportunity through the utilization of the vast technologies, expertise, resources of these partners, in addition to our talented internal team, to develop and sell innovative interventional technologies.

CorNova's first product, the Valecor Stent System, which received a CE Mark in late 2006, has acted as a platform for CorNova's next-generation stent technologies including the Valecor Platinum Coronary Stent System. CorNova also plans to introduce products with cardiovascular treatment guidance capabilities that will revolutionize the field of interventional medicine. CorNova believes that the combination of these breakthrough technologies will lead to a new era of improved endovascular treatment.